H.E. de Melker

2.0k total citations
38 papers, 1.5k citations indexed

About

H.E. de Melker is a scholar working on Epidemiology, Infectious Diseases and Health. According to data from OpenAlex, H.E. de Melker has authored 38 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Epidemiology, 14 papers in Infectious Diseases and 12 papers in Health. Recurrent topics in H.E. de Melker's work include Vaccine Coverage and Hesitancy (12 papers), Bacterial Infections and Vaccines (10 papers) and Influenza Virus Research Studies (9 papers). H.E. de Melker is often cited by papers focused on Vaccine Coverage and Hesitancy (12 papers), Bacterial Infections and Vaccines (10 papers) and Influenza Virus Research Studies (9 papers). H.E. de Melker collaborates with scholars based in Netherlands, United States and Canada. H.E. de Melker's co-authors include Frits R. Mooi, Nicoline van der Maas, M.A.E. Conyn-van Spaendonck, Guy A. M. Berbers, Liesbeth Mollema, Fiona van der Klis, J. F. P. Schellekens, Sabine C. de Greeff, Susan Hahné and Susan van den Hof and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and The Journal of Infectious Diseases.

In The Last Decade

H.E. de Melker

37 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H.E. de Melker Netherlands 21 1.1k 587 363 340 127 38 1.5k
M.A.E. Conyn-van Spaendonck Netherlands 23 1.3k 1.2× 764 1.3× 597 1.6× 354 1.0× 81 0.6× 47 1.9k
Hajime Kamiya Japan 20 813 0.7× 569 1.0× 433 1.2× 157 0.5× 89 0.7× 110 1.5k
William Walker Atkinson United Kingdom 5 1.1k 1.0× 231 0.4× 485 1.3× 579 1.7× 217 1.7× 10 1.7k
D O’Flanagan Ireland 23 1.2k 1.1× 203 0.3× 486 1.3× 432 1.3× 126 1.0× 79 1.7k
Leonard R. Friedland United States 24 646 0.6× 490 0.8× 459 1.3× 257 0.8× 77 0.6× 54 1.6k
J. Gaudelus France 19 968 0.9× 545 0.9× 395 1.1× 375 1.1× 61 0.5× 146 1.6k
Janet R. Gilsdorf United States 27 1.5k 1.4× 1.2k 2.0× 315 0.9× 197 0.6× 79 0.6× 96 2.4k
Maria Cristina Rota Italy 28 1.6k 1.5× 396 0.7× 554 1.5× 747 2.2× 262 2.1× 100 2.4k
Marco Aurélio Palazzi Sáfadi Brazil 26 1.6k 1.5× 1.4k 2.4× 495 1.4× 311 0.9× 103 0.8× 98 2.4k
H. C. Rümke Netherlands 27 1.8k 1.6× 972 1.7× 398 1.1× 162 0.5× 139 1.1× 60 2.4k

Countries citing papers authored by H.E. de Melker

Since Specialization
Citations

This map shows the geographic impact of H.E. de Melker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H.E. de Melker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H.E. de Melker more than expected).

Fields of papers citing papers by H.E. de Melker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H.E. de Melker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H.E. de Melker. The network helps show where H.E. de Melker may publish in the future.

Co-authorship network of co-authors of H.E. de Melker

This figure shows the co-authorship network connecting the top 25 collaborators of H.E. de Melker. A scholar is included among the top collaborators of H.E. de Melker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H.E. de Melker. H.E. de Melker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Woudenberg, Tom, et al.. (2020). Effect of vaccination on severity and infectiousness of measles during an outbreak in the Netherlands, 2013–2014. Epidemiology and Infection. 148. e81–e81. 4 indexed citations
2.
Kemmeren, Jeanet M., Nicoline van der Maas, Elise M. van de Putte, et al.. (2018). No evidence found for an increased risk of long-term fatigue following human papillomavirus vaccination of adolescent girls. Vaccine. 36(45). 6796–6802. 16 indexed citations
3.
Maas, Nicoline van der, et al.. (2017). Severe underestimation of pertussis related hospitalizations and deaths in the Netherlands: A capture-recapture analysis. Vaccine. 35(33). 4162–4166. 11 indexed citations
4.
Donken, Robine, H.E. de Melker, Nynke Y. Rots, Guy A. M. Berbers, & Mirjam J. Knol. (2015). Comparing vaccines: A systematic review of the use of the non-inferiority margin in vaccine trials. Vaccine. 33(12). 1426–1432. 28 indexed citations
5.
Mens, S. P. van, Anna M.M. van Deursen, Sabine C. de Greeff, et al.. (2014). Bacteraemic and non-bacteraemic/urinary antigen-positive pneumococcal community-acquired pneumonia compared. European Journal of Clinical Microbiology & Infectious Diseases. 34(1). 115–122. 12 indexed citations
6.
Waaijenborg, Sandra, Susan Hahné, Liesbeth Mollema, et al.. (2013). Waning of Maternal Antibodies Against Measles, Mumps, Rubella, and Varicella in Communities With Contrasting Vaccination Coverage. The Journal of Infectious Diseases. 208(1). 10–16. 120 indexed citations
7.
Mollema, Liesbeth, Gaby Smits, Guy A. M. Berbers, et al.. (2013). High risk of a large measles outbreak despite 30 years of measles vaccination in The Netherlands. Epidemiology and Infection. 142(5). 1100–1108. 37 indexed citations
8.
Mollers, Madelief, Mirte Scherpenisse, Fiona van der Klis, et al.. (2012). Prevalence of genital HPV infections and HPV serology in adolescent girls, prior to vaccination. Cancer Epidemiology. 36(6). 519–524. 25 indexed citations
9.
Maas, Nicoline van der, et al.. (2012). Incidence of Multiple Sclerosis in the General Population in the Netherlands, 1996–2008. Neuroepidemiology. 39(2). 96–102. 22 indexed citations
10.
Suijkerbuijk, Anita, Anna K. Lugnér, Wilfrid van Pelt, et al.. (2012). Assessing potential introduction of universal or targeted hepatitis A vaccination in the Netherlands. Vaccine. 30(35). 5199–5205. 6 indexed citations
11.
Greeff, Sabine C. de, Arnold Dekkers, Peter Teunis, et al.. (2009). Seasonal patterns in time series of pertussis. Epidemiology and Infection. 137(10). 1388–1395. 49 indexed citations
12.
Hontelez, Jan A. C., et al.. (2009). Effectiveness and impact of hepatitis B virus vaccination of children with at least one parent born in a hepatitis B virus endemic country: an early assessment. Journal of Epidemiology & Community Health. 64(10). 890–894. 6 indexed citations
13.
Versteegh, F. G. A., P. L. J. M. Mertens, H.E. de Melker, et al.. (2005). Age-specific long-term course of IgG antibodies to pertussis toxin after symptomatic infection with Bordetella pertussis. Epidemiology and Infection. 133(4). 737–748. 65 indexed citations
14.
Kortbeek, Laetitia M., H.E. de Melker, Irene Veldhuijzen, & M.A.E. Conyn-van Spaendonck. (2004). Population-based Toxoplasma seroprevalence study in The Netherlands. Epidemiology and Infection. 132(5). 839–845. 62 indexed citations
15.
Hof, Susan van den, et al.. (2003). Antibodies against mumps in The Netherlands as assessed by indirect ELISA and virus neutralization assay. Epidemiology and Infection. 131(1). 703–709. 18 indexed citations
16.
Termorshuizen, Fabian, J W Dorigo-Zetsma, H.E. de Melker, Susan van den Hof, & M.A.E. Conyn-van Spaendonck. (2000). The prevalence of antibodies to hepatitis A virus and its determinants in The Netherlands: a population-based survey. Epidemiology and Infection. 124(3). 459–466. 42 indexed citations
17.
Melker, H.E. de, et al.. (2000). Non-participation in a population-based seroprevalence study of vaccine-preventable diseases. Epidemiology and Infection. 124(2). 255–262. 26 indexed citations
18.
Melker, H.E. de, Susan van den Hof, Guy A. M. Berbers, et al.. (1999). A population-based study on tetanus antitoxin levels in the Netherlands. Vaccine. 18(1-2). 100–108. 26 indexed citations
19.
Melker, H.E. de, Guy A. M. Berbers, Nicolas Nagelkerke, & M.A.E. Conyn-van Spaendonck. (1999). Diphtheria Antitoxin Levels in the Netherlands: a Population-Based Study. Emerging infectious diseases. 5(5). 694–700. 25 indexed citations
20.
Melker, H.E. de & M.A.E. Conyn-van Spaendonck. (1998). Immunosurveillance and the evaluation of national immunization programmes: a population-based approach. Epidemiology and Infection. 121(3). 637–643. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M.A.E. Conyn-van Spaendonck Breakdown of academic impact, for papers by Hajime Kamiya Breakdown of academic impact, for papers by William Walker Atkinson Breakdown of academic impact, for papers by D O’Flanagan Breakdown of academic impact, for papers by Leonard R. Friedland Breakdown of academic impact, for papers by J. Gaudelus Breakdown of academic impact, for papers by Janet R. Gilsdorf Breakdown of academic impact, for papers by Maria Cristina Rota Breakdown of academic impact, for papers by Marco Aurélio Palazzi Sáfadi Breakdown of academic impact, for papers by H. C. Rümke
Rankless by CCL
2026